Meet Matthew Riordan, an experienced executive in the life science industry with a strong background in consulting and advising for pharmaceutical, biotechnology and medical devices clients. With a keen expertise and focus on new product development, in-line product growth, and value, pricing, and access strategy in both US and global markets, Matthew serves as a Partner and Chief Strategy Officer at Putnam Associates. Matthew has developed and implemented strategies and tactics in multiple therapeutic areas with a particular focus in hematology/oncology, immunology, and orphan disease markets. He has also overseen primary and secondary data resources to develop informed strategies for clients. With an MBA in Leadership in Healthcare from Yale School of Management and a BA in Economics from Boston College, Matthew is well equipped to tackle complex commercial strategy issues and has established himself as one of the most dynamic and highly respected strategy consultants in the life science industry.